Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Neutrophil transepithelial migration: evidence for sequential, contact-dependent signaling events and enhanced paracellular permeability independent of transjunctional migrationHeather A Edens, Boaz P Levi, David L Jaye, et al.Biorxiv : the Preprint Server for Biology|November 14, 2023
Interleukin-1 receptor antagonist is a conserved early factor for exacerbating tuberculosis susceptibilityOphelia V Lee, Daisy X Ji, Bruce A Rosa, et al.Journal of Immunological Methods|September 12, 2012
Purification and identification of cell surface antigens using lamprey monoclonal antibodiesCuiling Yu, Shabab Ali, Jonathan St-Germain, et al.Plos One|September 28, 2017
PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipientsMohammad S Hossain, Ghada M Kunter, Vicky F El-Najjar, et al.The Journal of Experimental Medicine|August 25, 2010
DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomasAnne Y Lai, Mehrnaz Fatemi, Archana Dhasarathy, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2011
Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunityMohammad S Hossain, David L Jaye, Brian P Pollack, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2009
Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantationJian-Ming Li, Lauren T Southerland, Ying Lu, et al.Genome Research|September 10, 2013
DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activationAnne Y Lai, Deepak Mav, Ruchir Shah, et al.Cancer Research|April 19, 2006
Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cellsPengbo Liu, Sumathi Ramachandran, Mohamed Ali Seyed, et al.Clinical Lymphoma, Myeloma & Leukemia|September 20, 2015
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic LeukemiaChristopher R Flowers, Jennifer R Brown, Hilary Rosenthal, et al.Pageof 7